Long-Term Engraftment by PSC Teratoma-Derived Myogenic Progenitors

Study Background and Research Question

Skeletal muscle regeneration relies heavily on the activity of satellite cells, a specialized stem cell pool marked by PAX7 expression. These cells reside beneath the basal lamina of myofibers and are critical for tissue repair after injury, as well as for the addition of myonuclei during muscle growth. However, the limited abundance of satellite cells in adult tissue—comprising only 1–2% of the mononuclear cell fraction—and the destructive harvesting methods required for their isolation have hindered their direct clinical application. Conventional protocols for generating myogenic progenitors from human induced pluripotent stem cells (hiPSCs) are complex and variable. This has led researchers to explore alternative in vivo strategies, including the use of hiPSC-derived teratomas as a source of skeletal myogenic progenitors. The central question addressed by Khosrowpour et al. (2025) is whether myogenic progenitors isolated from human PSC teratomas can engraft, mature, and expand the satellite cell pool over extended periods after transplantation.

Key Innovation from the Reference Study

The main innovation of this study lies in the use of human iPSC-derived teratomas as an in vivo platform to generate myogenic progenitor cells. The authors identify and isolate a highly specific CD82+ ERBB3+ NGFR+ cell population from these teratomas. This approach bypasses the technical hurdles of in vitro differentiation, yielding a population with robust myogenic potential. Upon transplantation into NSG-mdx4Cv mice—a dystrophic and immunodeficient model—the isolated cells not only engraft but also demonstrate long-term regenerative activity, forming new human Dystrophin+ muscle fibers and establishing a dynamic, self-renewing PAX7+ satellite cell pool. The temporal tracking of these engraftments, including muscle fiber maturation and satellite cell kinetics, provides key insights into the evolution and stability of human myogenic grafts in vivo.

Methods and Experimental Design Insights

The experimental workflow began with the generation of teratomas by injecting hiPSCs into immunodeficient mice. After teratoma formation, tissues were dissociated and subjected to fluorescence-activated cell sorting (FACS) to isolate CD82+ ERBB3+ NGFR+ myogenic progenitors. These cells were either transplanted directly into the injured tibialis anterior muscles of NSG-mdx4Cv mice or cryopreserved for later use.

Following transplantation, the mice were monitored at multiple time points up to eight months. Engraftment was assessed by immunostaining for human Dystrophin, PAX7, and MyHC isoforms to track muscle fiber formation, satellite cell pool dynamics, and fiber maturation. The study also evaluated the impact of cryopreservation on progenitor cell function, testing whether frozen-thawed cells retained their regenerative and engraftment potential.

Protocol Parameters

• Donor cell isolation: FACS isolation of CD82+ ERBB3+ NGFR+ cells from hiPSC-derived teratomas.
• Transplantation model: NSG-mdx4Cv mice with prior muscle injury to facilitate engraftment.
• Engraftment duration: Longitudinal analysis at 1, 4, and 8 months post-transplantation.
• Cryopreservation step: Cells were cryopreserved in standard conditions and tested for post-thaw viability and functional competence.
• Immunohistochemistry: Detection of human Dystrophin, PAX7, and MyHC isoforms to confirm human origin, satellite cell identity, and fiber maturation.

Core Findings and Why They Matter

Transplanted CD82+ ERBB3+ NGFR+ progenitors engrafted robustly and generated substantial numbers of human Dystrophin+ muscle fibers, which increased in size and number over time. Notably, the study documented a dynamic expansion of the PAX7+ human satellite cell pool in recipient muscle. This pool initially expanded following transplantation and then underwent a moderate decline between 4 and 8 months as muscle fibers matured—an indication of a maturing and self-regulating graft environment. Myosin heavy chain (MyHC) isoform analysis revealed a temporal progression from embryonic to neonatal and slow fiber types, reflecting physiological maturation of the regenerated tissue. Importantly, cryopreserved progenitors retained their capacity for engraftment and regeneration, supporting the feasibility of creating cell banks for future therapeutic use. These results demonstrate that hiPSC-derived teratomas can serve as a renewable source of human myogenic stem cells with durable in vivo functionality, providing a foundation for new strategies in muscle regeneration and disease modeling (reference).

Comparison with Existing Internal Articles

Several internal articles discuss the critical role of Rho/ROCK signaling in cytoskeletal dynamics, stem cell viability, and transplantation outcomes. For example, the article "Y-27632 Dihydrochloride: Selective ROCK Inhibitor for Cytoskeletal Studies" highlights how inhibition of Rho-associated protein kinases (ROCK1/2) supports cell survival and reduces apoptosis during dissociation and transplantation steps—a key consideration when isolating and transferring sensitive myogenic progenitors. Another resource, "Y-27632 dihydrochloride: Selective ROCK1/2 Inhibitor for Cytoskeletal Studies", provides workflow guidance for using ROCK inhibitors like Y-27632 to enhance stem cell viability and engraftment efficiency, which aligns with the technical requirements of the transplantation model described in the reference study. These resources collectively support the translational rationale for integrating ROCK inhibition into protocols for myogenic progenitor preparation and transplantation.

Limitations and Transferability

While the study establishes the long-term regenerative potential of human PSC teratoma-derived myogenic progenitors, several limitations must be noted. The use of NSG-mdx4Cv mice, which are both immunodeficient and dystrophic, may not fully recapitulate the immune and tissue environment of human patients. The teratoma-based approach, although effective for generating a rich source of progenitors, raises safety considerations regarding tumorigenicity and scalability for clinical translation. In addition, the engraftment dynamics and maturation observed in the murine host may differ from human muscle physiology. Nevertheless, the demonstration that cryopreserved progenitors retain function is an important step toward practical application, suggesting these methods could be adapted for biobanking and delayed use in research or therapy.

Research Support Resources

For researchers aiming to replicate or extend these findings, robust cell viability and cytoskeletal integrity during isolation and transplantation are critical. The use of selective ROCK inhibitors such as Y-27632 dihydrochloride (SKU A3008) can enhance survival and reduce cellular stress by inhibiting Rho-mediated stress fiber formation and modulating cell cycle transitions, as supported in internal reviews (relevant scenario-driven guidance). APExBIO’s Y-27632 dihydrochloride is frequently applied in workflows where high stem cell viability and reproducible engraftment are required, including protocols involving human and rodent stem and progenitor cells. Researchers are advised to consult specific product handling and storage recommendations to maintain compound stability and experimental reproducibility.